Beaphar Multiwormer For Cats, Tablets

Revised: 08 June 2010

AN: 00309/2010


Name of the Veterinary Medicinal Product

Beaphar Multiwormer for Cats, Tablets

Qualitative and Quantitative Composition

Tapeworm tablets (fawn)

Active substance mg/tablet

Dichlorophen 250.00

Excipients mg/tablet

Caramel 15712 (E150) 4.0

For full list of excipients, see section 6.1

Roundworm tablets (pink)

Active substance mg/tablet

Piperazine Citrate 125.00

Excipients mg/tablet

Erythrocine Lake (E127) 0.25

For full list of excipients, see section 6.1

Pharmaceutical form


Roundworm tablet: Slightly mottled pink, circular bi-convex tablet embossed with an incomplete break-line on one face.

Tapeworm tablet: Mottled fawn to off-white, circular slightly bi-convex tablet embossed on one face with an incomplete break line.

Clinical Particulars

4.1 Target species

Cats over 6 months of age

Indications for use, specifying the target species

For the treatment of roundworm (Ascarids) and tapeworm infections in cats over six months old


Do not treat cats less than 6 months old.

Do not repeat the treatment if vomiting occurs shortly after dosing.

4.4 Special warnings for each target species

Do not treat cats under 0.6 kg (1.5 lb), or less than 6 months old.

Do not repeat treatment if the cat vomits after administration.

Special precautions for use

i. Special precautions for use in animals

Consult a veterinary surgeon before treating animals with a history of epilepsy or severe renal dysfunction.

It is important to establish the bodyweight of the animal before treatment to ensure correct dosage administration.

Special precautions to be taken by the person administering the medicinal product to animals

Wash hands thoroughly after handling tablets.

Accidental eye contact – rinse thoroughly with clean running water.

If irritation persists seek medical advice.

Accidental ingestion by humans – drink plenty of water and seek medical advice.

Adverse reactions (frequency and seriousness)

Dichlorophen may cause excessive salivation in some cats, due to its bitter taste. Idiosyncratic reactions to dichlorophen have been recorded in some animals, characterised by ataxia, depression, and occasionally vomiting.

4.7 Use during pregnancy, lactation or lay

Consult a veterinary surgeon before treating pregnant animals.

Nursing female cats should be treated 2 weeks after giving birth and every two weeks until weaning.

4.8 Interaction with other medicinal products and other forms of interaction

None known

4.9 Amounts to be administered and administration route

For oral administration

Treatment consists of three doses given at weekly intervals. Administer one pink tablet per 1.3 kg (3 lb) bodyweight on day 1, then one fawn tablet per 1.3 kg on day 8, and one pink tablet per 1.3 kg on day 15. Tablets may be taken whole, or crushed and sprinkled on the cat’s food. Do not remove tablets from strip until required for treatment.

Cats should be treated every 3 months.

4.10 Overdose (symptoms, emergency procedures, antidotes) if necessary

Piperazine Citrate Dichlorophen

Symptoms: Vomiting and diarrhoea Vomiting

Depression General weakness

Ataxia and muscle weakness Ataxia


Emergency Procedures: Consult a veterinary surgeon.

Treat symptomatically and supportively.

Keep animal warm and calm.

Symptoms reverse in 24-48 hours.

4.11 Withdrawal period(s)

Not applicable.

Pharmacological properties

ATCvet codes:QP52AG01, QP52AH01

Pharmacodynamic properties

Piperazine acts as an anthelmintic by causing nerve paralysis of the worm, with subsequent expulsion.

Dichlorophen is effective against most common cestodes, and also has antibacterial and antifungal properties.

5.2 Pharmacokinetic particulars

The citrate is quickly absorbed in the cat and excreted in the urine.

Pharmaceutical particulars

List of excipients

Tapeworm tablets (fawn)

Caramel 15712 (E150)

Maize Starch

Pregelatinised Starch

Magnesium Stearate

Roundworm tablets (pink)

Erythrosine Lake (E127)

Cellulose Microcrystalline

Silica Colloidal Anhydrous

Magnesium Stearate


None known.

Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 2 years.

Special precautions for storage

Do not store above 25ºC.

Do not remove tablets from strip until required for treatment

Any part-used tablets should be discarded.

Nature and composition of immediate packaging

8 pink roundworm tablets and 4 fawn tapeworm tablets in the following pack:

Container: PVC – aluminium foil blister strip

Closure: Heat – seal

Secondary pack: One blister of 8 roundworm tablets with one blister of 4 fawn tapeworm tablets per carton.

Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products, if appropriate

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Marketing authorisation holder

Beaphar UK Ltd.

Homefield Road




Marketing authorisation number

Vm 13907/4006

Date of first authorisation/renewal of the authorisation

Date of first authorisation: 21 September 1994

Date of revision of the text

June 2010

Page 5 of 5